Japan’s AMED Taps Genomics In Rare Disease Project
This article was originally published in PharmAsia News
Executive Summary
Making good on plans outlined earlier this year, and mirroring similar initiatives elsewhere, Japan's new Agency for Medical R&D has kicked off a new project to use genome analysis to help identify and treat rare diseases, as part of its remit to encourage collaborative research and promote public health.